Natalie

Medical Affairs @braeburnrx

[Natalie @Natbud21]

Honored to have had the opportunity to represent Braeburn at #ASAM2018 and collaborate with nationally-recognized leaders in addiction medicine and addiction psychiatry.

[Natalie @Natbud21]

@JetBlue I’m extremely disappointed with the fare changes communicated this morning. The best perk of flying Jetblue as a Mosaic was the flexibility of your reservation even with the basic fare and was the reason I chose Jetblue for the 90+ flights per year that I take. #jetblue

[Mike Derkacz @mderkacz]

We are pleased to announce that FDA has granted our Citizen Petition and revoked orphan designation, enabling access to new treatments for patients with OUD. https://t.co/rnUtzuNTn7

[Natalie @Natbud21]

@netflix

[Mike Derkacz @mderkacz]

A loophole in the Orphan Drug Act could prevent approval of new medications to treat opioid use disorder in the midst of a crisis that could spike to 250 deaths per day if access to treatment doesn’t improve. https://t.co/CMYoiyCtmo

[Braeburn @braeburnrx]

.@NPR story highlights the importance of making new tools available for patients and physicians during an opioid addiction crisis. https://t.co/LMmCFxV3r0

[Braeburn @braeburnrx]

At Braeburn, everything we think, say and do is with patients in mind. Filing this Petition was necessary to bring vital treatment options to patients suffering with #opioid #addiction as soon as possible. https://t.co/WefJHKdERr

[Braeburn @braeburnrx]

We���re excited to be at #AMCPAnnual in San Diego to learn about innovations and issues in managed care and specialty pharmacy! @AMCPorg

[Braeburn @braeburnrx]

If you’re @AAAP2018 this weekend, stop by our posters to learn more about the clinical data related to Braeburn’s investigational weekly and monthly buprenorphine injection. Check out our other publications here: https://t.co/SJ3hhs12Vr. #AAAP29

[Braeburn @braeburnrx]

In honor of National Recovery Month, we wear purple to support people in all stages of recovery. #RecoveryMonth #OpioidAwareness @RecoveryMonth

[Paul Johnson @paulj_braeburn]

#oudheros Great work by Dr. Herring in CA taking care of people in the Emergency Department! Inside one of the rare E.R.s in America treating opioid addiction on demand - The New York Timeshttps://apple.news/AC-DKB6qdTXycacvEmlTXyQ

[Braeburn @braeburnrx]

We find inspiration in our coworkers who keep patients at the center of everything they do. #TeamBraeburn https://t.co/7na2CLQHEu

[Braeburn @braeburnrx]

We are looking for Medical Science Liaison candidates to join Braeburn’s growing Medical Affairs team. Check out our job posting! #TeamBraeburn #MedAffairs https://t.co/qIYngPvzSj

[Mike Derkacz @mderkacz]

How opioids reshape your brain, and what scientists are learning about addiction https://t.co/7LSmtYrDdS via @phillydotcom

[Mike Derkacz @mderkacz]

Check out the second episode from @AddictionPolicy - understanding risk factors is an important step in preventing substance use disorder. #opioidawareness https://t.co/8lgyB9cA86 via @YouTube

[Mike Derkacz @mderkacz]

FDA has assigned a December 26 goal date for our Fast Track and Priority Review NDA for CAM2038 Weekly & Monthly injectable. CAM2038 represents a potential game-changing treatment for #OpioidUseDisorder. https://t.co/pcOmMCzuys

[Braeburn @braeburnrx]

Braeburn is honored to join Steve Fera of @IBX, @Dr_DownBlock1, @pkunzhoward and representatives from @PADrugAlcohol and @NOPETaskForce today on Capitol Hill to discuss emergency department protocols for opioid overdoses. Follow us this morning for live tweets of the event!

[Natalie @Natbud21]

Honored to have had the opportunity to represent Braeburn at #CPDD2018 and collaborate with nationally-recognized leaders in addiction medicine and addiction psychiatry.

[Mike Derkacz @mderkacz]

I’m thrilled to announce our pivotal Phase 3 efficacy and safety study results were published in @JAMAInternalMed! We are excited to continue to share evidence-based information to support patients and HCPs dealing with opioid use disorder. https://t.co/FGBDKnhqgt

[Nancy Donahue @DonahueNancy]

We’re pleased to announce the launch of Brave Action, a disease-focused initiative to support healthcare providers and increase access to resources aimed at fighting the OUD epidemic.

https://t.co/2dCNr5DATy